Conversion of the CD4+ T cell profile from TH2-dominant type to TH1-dominant type after varicella-zoster virus infection in atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 2, 1997, Pages 274-282

  Fujimura, Takao ^a   Yamanashi, Rika ^a   Masuzawa, Mikio ^a   Fujita, Yuhsuke ^a   Katsuoka, Kensei ^a   Nishiyama, Sigeo ^a   Mitsuyama, Masao ^b   Nomoto, Kikuo ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Cytokines; IL 12; Varicella

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

EID: 0030855301     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70236-7     Document Type: Article

References (48)

1. Sampson HA, Hanifin J. Atopic dermatitis. In: Jordon RE, editor. Immunologic diseases of the skin. East Norwalk: Appleton and Lange, 1991:229-38.
2. Reinhold U, Kukel S, Goeden B. Neumann U, Kreysel HW. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991;86:444-8.
3. Zachary CB, Allen MH, Macdonald DM. In situ quantification of T-lymphocyte subsets and Langerhans cell in the inflammatory infiltrate of atopic eczema. Br J Dermatol 1985;112:149-56.
4. Munro CS, Levell NJ, Shuster S, Friedmann PS. Maintenance treatment with cyclosporin in atopic eczema. Br J Dermatol 1994; 130:376-80.
5. Granlund H, Erkko P, Sinisalo M, Reitamo S. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br J Dermatol 1995;132:106-12.
6. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
7. Tang MLK, Kemp AS. Spontaneous expression of IL-4 mRNA in lymphocytes from children with atopic dermatitis. Clin Exp Immunol 1994;97:491-8.
8. + T lymphocytes in atopic patients. J Immunol 1990;144:4651-6.
9. Hamid Q, Boguniiewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clan Invest 1994;94:870-6.
10. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-94.
11. Ramb-Lindhauer CH, Feldmann A, Rotte M, Newmann CH. Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin. Arch Dermatol Res 1991;283:71-6.
12. Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RAW, Kapsenberg ML. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991;147:2942-9.
13. H2 clone? Br J Dermatol 1993;128:102.
14. H2 imbalance? Dermatology 1994;188: 255-7.
15. Verbov J, Hart A. Severe varicella in a child with atopic eczema and ichthyosis. Practitioner 1986;230:15-6.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
17. H1 type cytokine mRNA in sporotrichosis lesions. Acta Derm Venereol (Stockh) 1996;76:321-2.
18. Ohyama Y, Nakamura S, Matsuzaki G, et al. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:1376-84.
19. Kawamura I, Tsukada H, Yoshikawa H, Fujita M, Nomoto K, Mitsuyama M. IFN-γ-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. J Immunol 1992;148:2887-93.
20. H cells. J Exp Med 1993;177:1199-204.
21. + T cells. Immunol Rev 1991;123:209-29.
22. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8.
23. Sher A, Gazzinelli RT, Oswald IP, et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992;127:183-204.
24. + T cells through IL-12 produced by Ltsteria-induced macrophages. Science 1993;260:547-9.
25. H2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991;147:3149-55.
26. + T cells during initiation of infection. J Exp Med 1994;179:447-56.
27. H2 cells in a rodent malaria infection. Science 1993;260:1931-4.
28. + T-cell subsets. Proc Natl Acad Sci U S A 1994;91:18-22.
29. Del Prete GF, De Carli M, Mastromauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-50.
30. H2: doubt no more. Immunol Today 1991;12:256-7.
31. Yamamura M. Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: Cytokine profiles in leprosy lesion. Science 1991;254:277-9.
32. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicão-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmanaisis. J Clin Invest 1993;91:1390-5.
33. H2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991;146:1169-74.
34. Parronchi P, Macchia D, Piccinni M-P, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 1991;88:4538-42.
35. Hsieh C-S, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc Natl Acad Sci U S A 1992;89:6065-9.
36. + T cells from T cell receptor transgenic mice. J Exp Med 1992;176:1091-8.
37. Wu C-Y, Demeure C, Kiniwa M, Gately M, Delespesse G. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J Immunol 1993;151:1938-49.
38. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-45.
39. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-81.
40. Zhang M, Gately MK, Wang E, et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-9.
41. Sieling PA, Wang X-H, Gately MK, et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994;153:3639-47.
42. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1944;76:241-51.
43. Chre'tien I, Péne J, Briére F, de Waal RM, Rousset F, de Vries JE. Regulation of human IgG synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of IL-4 and IFN-γ. Eur J Immunol 1990;20:243-51.
44. H2 cytokine responses induced by eggs of Schistosoma mansoni. J Immunol 1994;153:1707-13.
45. Finkelman FD, Madden KB, Cheever AW, et al. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994;179:1563-72.
46. Tamg MLK, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-γ secretion in neonates and subsequent atopy. Lancet 1994;344:983-5.
47. Péne J. Rivier A, Lagier B, Becker WM, Michel F-B, Bousquet J. Differences in IL-4 release by PBMC are related with heterogeneity of atopy. Immunol 1994;81:58-64.
48. Reinhold U, Wehrmann W, Kukel S, Kieysel HW. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol 1990;79:374-9.